/PRNewswire/ Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets will present multispecific.
PHILADELPHIA, Sept. 27, 2023 Context Therapeutics Inc. , a biopharmaceutical company advancing medicines for solid tumors, today announced a poster regarding the Company’s preclinical asset,.
Last summer, the American Historical Association’s former president, James H. Sweet, issued an apology. Expressing regret for “the way I have alienated some of my Black colleagues and friends,” Sweet walked back a claim he had earlier made that characterized as “anachronistic” and essentia.
A New Book Reexamines the Mythos Around America s Working Class—And Recognizes the Long Struggle of the Black Community for Fair Working Conditions indyweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indyweek.com Daily Mail and Mail on Sunday newspapers.
CTIM-76 IND filing on track for Q1 2024 Preclinical data on CLDN6 bispecific antibody CTIM-76 presented at AACR Annual Meeting 2023 Cash and cash equivalents of $29.8 million as of March 31,. | May 10, 2023